

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 9.49682626 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 8.00900201 |
| 3 | angiotensin maturation (GO:0002003) | 7.68654649 |
| 4 | flavonoid metabolic process (GO:0009812) | 6.59434227 |
| 5 | lipoprotein transport (GO:0042953) | 6.41725805 |
| 6 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.39567782 |
| 7 | vitamin A metabolic process (GO:0006776) | 6.17120755 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 5.82270895 |
| 9 | digestive system process (GO:0022600) | 5.55886617 |
| 10 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.52823616 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.49802757 |
| 12 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.40655502 |
| 13 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.23047026 |
| 14 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.23047026 |
| 15 | endocrine process (GO:0050886) | 5.23047026 |
| 16 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.20137358 |
| 17 | actin filament depolymerization (GO:0030042) | 5.17803646 |
| 18 | adhesion of symbiont to host cell (GO:0044650) | 5.08129839 |
| 19 | virion attachment to host cell (GO:0019062) | 5.08129839 |
| 20 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.02688434 |
| 21 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.02688434 |
| 22 | fructose metabolic process (GO:0006000) | 4.97408188 |
| 23 | regulation of cGMP biosynthetic process (GO:0030826) | 4.90965436 |
| 24 | regulation of respiratory burst (GO:0060263) | 4.89872911 |
| 25 | regulation of bile acid biosynthetic process (GO:0070857) | 4.88381987 |
| 26 | drug catabolic process (GO:0042737) | 4.83162163 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.74999695 |
| 28 | regulation of systemic arterial blood pressure (GO:0003073) | 4.74569631 |
| 29 | intestinal epithelial cell development (GO:0060576) | 4.66735380 |
| 30 | drug metabolic process (GO:0017144) | 4.56436609 |
| 31 | uronic acid metabolic process (GO:0006063) | 4.56197127 |
| 32 | glucuronate metabolic process (GO:0019585) | 4.56197127 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.50922303 |
| 34 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.47731190 |
| 35 | sulfation (GO:0051923) | 4.38196005 |
| 36 | arginine metabolic process (GO:0006525) | 4.34895583 |
| 37 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.34778115 |
| 38 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.34778115 |
| 39 | phospholipid efflux (GO:0033700) | 4.31826188 |
| 40 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.28246760 |
| 41 | sulfate transmembrane transport (GO:1902358) | 4.24745284 |
| 42 | transepithelial transport (GO:0070633) | 4.23099069 |
| 43 | plasma lipoprotein particle assembly (GO:0034377) | 4.17146561 |
| 44 | regulation of cGMP metabolic process (GO:0030823) | 4.11293891 |
| 45 | positive regulation of respiratory burst (GO:0060267) | 4.09604459 |
| 46 | antibacterial humoral response (GO:0019731) | 4.09189791 |
| 47 | adhesion of symbiont to host (GO:0044406) | 4.08358409 |
| 48 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.06585807 |
| 49 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.06530331 |
| 50 | modified amino acid transport (GO:0072337) | 4.06250037 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.01285172 |
| 52 | antimicrobial humoral response (GO:0019730) | 4.00734240 |
| 53 | sperm capacitation (GO:0048240) | 3.98075835 |
| 54 | peptide catabolic process (GO:0043171) | 3.98062378 |
| 55 | positive regulation of pseudopodium assembly (GO:0031274) | 3.96604512 |
| 56 | glucose 6-phosphate metabolic process (GO:0051156) | 3.92134852 |
| 57 | bicarbonate transport (GO:0015701) | 3.90902716 |
| 58 | protein-lipid complex assembly (GO:0065005) | 3.90723596 |
| 59 | glycolipid catabolic process (GO:0019377) | 3.90304932 |
| 60 | purine nucleotide salvage (GO:0032261) | 3.89762769 |
| 61 | regulation of cellular extravasation (GO:0002691) | 3.88281486 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 3.81460152 |
| 63 | membrane repolarization during action potential (GO:0086011) | 3.78784711 |
| 64 | O-glycan processing (GO:0016266) | 3.76396885 |
| 65 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.75154804 |
| 66 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75044306 |
| 67 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.74714492 |
| 68 | vitamin transmembrane transport (GO:0035461) | 3.73349708 |
| 69 | thyroid hormone metabolic process (GO:0042403) | 3.72772752 |
| 70 | transcytosis (GO:0045056) | 3.69261860 |
| 71 | bile acid and bile salt transport (GO:0015721) | 3.68856496 |
| 72 | lipoprotein metabolic process (GO:0042157) | 3.67589724 |
| 73 | response to hepatocyte growth factor (GO:0035728) | 3.65563239 |
| 74 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.65563239 |
| 75 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.63411077 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.62309279 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60246942 |
| 78 | regulation of chemokine secretion (GO:0090196) | 3.59931130 |
| 79 | diacylglycerol metabolic process (GO:0046339) | 3.59735664 |
| 80 | alkaloid metabolic process (GO:0009820) | 3.58218536 |
| 81 | cytidine metabolic process (GO:0046087) | 3.57464928 |
| 82 | cytidine catabolic process (GO:0006216) | 3.57464928 |
| 83 | cytidine deamination (GO:0009972) | 3.57464928 |
| 84 | digestion (GO:0007586) | 3.55611009 |
| 85 | regulation of pseudopodium assembly (GO:0031272) | 3.54835594 |
| 86 | innate immune response in mucosa (GO:0002227) | 3.53928538 |
| 87 | renal system process involved in regulation of blood volume (GO:0001977) | 3.53692172 |
| 88 | sulfate transport (GO:0008272) | 3.53135787 |
| 89 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.52365703 |
| 90 | sulfur compound transport (GO:0072348) | 3.52145014 |
| 91 | drinking behavior (GO:0042756) | 3.51744775 |
| 92 | NADH metabolic process (GO:0006734) | 3.50336210 |
| 93 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.42560175 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42402503 |
| 95 | cholesterol efflux (GO:0033344) | 3.42261546 |
| 96 | vitamin transport (GO:0051180) | 3.41887533 |
| 97 | glomerular filtration (GO:0003094) | 3.39317734 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.39286042 |
| 99 | sterol homeostasis (GO:0055092) | 3.37968538 |
| 100 | fat-soluble vitamin metabolic process (GO:0006775) | 3.34097196 |
| 101 | bile acid metabolic process (GO:0008206) | 3.31460443 |
| 102 | sterol transport (GO:0015918) | 3.31299939 |
| 103 | cholesterol transport (GO:0030301) | 3.31299939 |
| 104 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.29855692 |
| 105 | cellular response to nitric oxide (GO:0071732) | 3.28979808 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.28885884 |
| 107 | epithelial structure maintenance (GO:0010669) | 3.28426325 |
| 108 | regulation of protein glycosylation (GO:0060049) | 3.25967892 |
| 109 | glycerol metabolic process (GO:0006071) | 3.25943908 |
| 110 | glycosylceramide metabolic process (GO:0006677) | 3.25280949 |
| 111 | positive regulation of cGMP metabolic process (GO:0030825) | 3.23345581 |
| 112 | ceramide catabolic process (GO:0046514) | 3.22818244 |
| 113 | mRNA modification (GO:0016556) | 3.20651931 |
| 114 | glycoside metabolic process (GO:0016137) | 3.20309158 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.19794653 |
| 116 | negative regulation of sterol transport (GO:0032372) | 3.19794653 |
| 117 | cyclooxygenase pathway (GO:0019371) | 3.18345795 |
| 118 | killing of cells of other organism (GO:0031640) | 3.17728109 |
| 119 | disruption of cells of other organism (GO:0044364) | 3.17728109 |
| 120 | auditory receptor cell differentiation (GO:0042491) | 3.17479053 |
| 121 | regulation of digestive system process (GO:0044058) | 3.16146189 |
| 122 | midgut development (GO:0007494) | 3.15921469 |
| 123 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.13255488 |
| 124 | arginine catabolic process (GO:0006527) | 3.11879131 |
| 125 | hepatocyte apoptotic process (GO:0097284) | 3.11832953 |
| 126 | vitamin biosynthetic process (GO:0009110) | 3.09632567 |
| 127 | cGMP-mediated signaling (GO:0019934) | 3.09231654 |
| 128 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08338687 |
| 129 | defense response to fungus (GO:0050832) | 3.07904003 |
| 130 | cGMP biosynthetic process (GO:0006182) | 3.07286329 |
| 131 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.07021826 |
| 132 | glomerulus development (GO:0032835) | 3.06924482 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 3.05775684 |
| 134 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.05343928 |
| 135 | mucosal immune response (GO:0002385) | 3.04252327 |
| 136 | renal filtration (GO:0097205) | 3.04040261 |
| 137 | response to nitric oxide (GO:0071731) | 3.03589126 |
| 138 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.03513502 |
| 139 | cellular glucuronidation (GO:0052695) | 3.02431718 |
| 140 | eosinophil chemotaxis (GO:0048245) | 3.01983293 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.01661261 |
| 142 | sexual reproduction (GO:0019953) | 3.00964696 |
| 143 | GDP-mannose metabolic process (GO:0019673) | 3.00479020 |
| 144 | hormone catabolic process (GO:0042447) | 2.99877924 |
| 145 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.99724833 |
| 146 | regulation of cholesterol homeostasis (GO:2000188) | 2.97899183 |
| 147 | phenylpropanoid metabolic process (GO:0009698) | 2.92769997 |
| 148 | exogenous drug catabolic process (GO:0042738) | 2.90308022 |
| 149 | urea cycle (GO:0000050) | 2.90001017 |
| 150 | urea metabolic process (GO:0019627) | 2.90001017 |
| 151 | regulation of viral release from host cell (GO:1902186) | 2.89925636 |
| 152 | diol metabolic process (GO:0034311) | 2.89445540 |
| 153 | homocysteine metabolic process (GO:0050667) | 2.89341110 |
| 154 | proline biosynthetic process (GO:0006561) | 2.88173412 |
| 155 | peptide hormone processing (GO:0016486) | 2.87847390 |
| 156 | organ or tissue specific immune response (GO:0002251) | 2.85852042 |
| 157 | drug transport (GO:0015893) | 2.85719250 |
| 158 | intestinal absorption (GO:0050892) | 11.6790964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 6.32066021 |
| 2 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 4.30627907 |
| 3 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.19686135 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.83005678 |
| 5 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 3.62910993 |
| 6 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.33245482 |
| 7 | SOX2_20726797_ChIP-Seq_SW620_Human | 3.22647914 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.21142635 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90969031 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.85035749 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.79626403 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62438951 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.62036749 |
| 14 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.50825928 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33319649 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.30446900 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25077935 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12397921 |
| 19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12162298 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11950475 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 11.7930560 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.86728250 |
| 23 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.85969844 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85604064 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82673948 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79560007 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.79477626 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.71377293 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71239099 |
| 30 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60792005 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55251046 |
| 32 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55035409 |
| 33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53883629 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53185549 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51559109 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43324753 |
| 37 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43317766 |
| 38 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42928730 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42880233 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35805980 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34392005 |
| 42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34223920 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31855749 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30776392 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.29939573 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28718340 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24387807 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21300254 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19380414 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19219853 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17290861 |
| 52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14748372 |
| 53 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12309455 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11185035 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11185035 |
| 56 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.09860724 |
| 57 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07161998 |
| 58 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06601309 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05792199 |
| 60 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05517441 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05457685 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04844867 |
| 63 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02925456 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02775669 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01926078 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01639564 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01568291 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99652023 |
| 69 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.99418104 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99029315 |
| 71 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97648511 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96955992 |
| 73 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96467906 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96006208 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95334208 |
| 76 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95251166 |
| 77 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.95128185 |
| 78 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94739601 |
| 79 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.94521884 |
| 80 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93740248 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92481489 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92355866 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92252828 |
| 84 | NCOR_22424771_ChIP-Seq_293T_Human | 0.91585177 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90470966 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90387241 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90286119 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89441378 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89348828 |
| 90 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88677971 |
| 91 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.88543590 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88301182 |
| 93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88107726 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87806998 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87794804 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87532881 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87220472 |
| 98 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86511874 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86034748 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85978314 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85066161 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84977126 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84962427 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84875685 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84014124 |
| 106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84010052 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83954714 |
| 108 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83815454 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83802007 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83664969 |
| 111 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.83343936 |
| 112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83274807 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82735489 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82305867 |
| 115 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.81975407 |
| 116 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81637428 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81562184 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81147529 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.80293707 |
| 120 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.79762288 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77550742 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77517344 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77394641 |
| 124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77195540 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77087688 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76934244 |
| 127 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76277241 |
| 128 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75558535 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74983352 |
| 130 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.74723937 |
| 131 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.74723937 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73008435 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.72929430 |
| 134 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.72161345 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.70255965 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69819906 |
| 137 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.69692556 |
| 138 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68480493 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.66429968 |
| 140 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66309404 |
| 141 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.65782698 |
| 142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.64753661 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64123179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.17232590 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.23334657 |
| 3 | MP0000462_abnormal_digestive_system | 4.09464377 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.96522496 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.89802058 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.65979920 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.40967552 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.27511251 |
| 9 | MP0003866_abnormal_defecation | 3.12957437 |
| 10 | MP0003252_abnormal_bile_duct | 3.00418757 |
| 11 | MP0009840_abnormal_foam_cell | 2.90799962 |
| 12 | MP0001663_abnormal_digestive_system | 2.74994675 |
| 13 | MP0005381_digestive/alimentary_phenotyp | 2.61340465 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.59928663 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.58017547 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.51012220 |
| 17 | MP0001873_stomach_inflammation | 2.47607972 |
| 18 | MP0000490_abnormal_crypts_of | 2.44330014 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37142672 |
| 20 | MP0000537_abnormal_urethra_morphology | 2.33628431 |
| 21 | MP0002822_catalepsy | 2.31369868 |
| 22 | MP0001664_abnormal_digestion | 2.17405922 |
| 23 | MP0008004_abnormal_stomach_pH | 2.06179155 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.02172481 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.98471994 |
| 26 | MP0000477_abnormal_intestine_morphology | 1.92998075 |
| 27 | MP0004858_abnormal_nervous_system | 1.90138982 |
| 28 | MP0005365_abnormal_bile_salt | 1.80460606 |
| 29 | MP0004147_increased_porphyrin_level | 1.77760974 |
| 30 | MP0005409_darkened_coat_color | 1.73141268 |
| 31 | MP0009697_abnormal_copulation | 1.72364832 |
| 32 | MP0000538_abnormal_urinary_bladder | 1.70084758 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.68664479 |
| 34 | MP0004043_abnormal_pH_regulation | 1.64134841 |
| 35 | MP0005377_hearing/vestibular/ear_phenot | 1.63327936 |
| 36 | MP0003878_abnormal_ear_physiology | 1.63327936 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.59661496 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.52638723 |
| 39 | MP0006054_spinal_hemorrhage | 1.44959105 |
| 40 | MP0003283_abnormal_digestive_organ | 1.44026873 |
| 41 | MP0008872_abnormal_physiological_respon | 1.42900801 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.34996791 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.23289435 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.22596014 |
| 45 | MP0002796_impaired_skin_barrier | 1.19795956 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.15977032 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.13640718 |
| 48 | MP0005670_abnormal_white_adipose | 1.11590674 |
| 49 | MP0004270_analgesia | 1.09156876 |
| 50 | MP0001849_ear_inflammation | 1.08067802 |
| 51 | MP0001756_abnormal_urination | 1.06779193 |
| 52 | MP0005448_abnormal_energy_balance | 1.04269428 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.03630206 |
| 54 | MP0003315_abnormal_perineum_morphology | 0.97386550 |
| 55 | MP0000230_abnormal_systemic_arterial | 0.97371702 |
| 56 | MP0005535_abnormal_body_temperature | 0.94798342 |
| 57 | MP0002098_abnormal_vibrissa_morphology | 0.93367292 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 0.93017940 |
| 59 | MP0000470_abnormal_stomach_morphology | 0.92922489 |
| 60 | MP0000467_abnormal_esophagus_morphology | 0.92690800 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 0.92317110 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 0.92097716 |
| 63 | MP0009785_altered_susceptibility_to | 0.92024606 |
| 64 | MP0002254_reproductive_system_inflammat | 0.91882594 |
| 65 | MP0001765_abnormal_ion_homeostasis | 0.91472153 |
| 66 | MP0001485_abnormal_pinna_reflex | 0.90539624 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89804046 |
| 68 | MP0003718_maternal_effect | 0.89613785 |
| 69 | MP0003724_increased_susceptibility_to | 0.89231853 |
| 70 | MP0000613_abnormal_salivary_gland | 0.89129697 |
| 71 | MP0009384_cardiac_valve_regurgitation | 0.88596332 |
| 72 | MP0002132_abnormal_respiratory_system | 0.88561546 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.87903819 |
| 74 | MP0005332_abnormal_amino_acid | 0.87118753 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.83094767 |
| 76 | MP0010678_abnormal_skin_adnexa | 0.82521790 |
| 77 | MP0000566_synostosis | 0.82419669 |
| 78 | MP0004947_skin_inflammation | 0.81553731 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.80908338 |
| 80 | MP0005451_abnormal_body_composition | 0.79043087 |
| 81 | MP0003329_amyloid_beta_deposits | 0.78486761 |
| 82 | MP0001835_abnormal_antigen_presentation | 0.78456918 |
| 83 | MP0005387_immune_system_phenotype | 0.77859362 |
| 84 | MP0001790_abnormal_immune_system | 0.77859362 |
| 85 | MP0009764_decreased_sensitivity_to | 0.77481112 |
| 86 | MP0002971_abnormal_brown_adipose | 0.77444247 |
| 87 | MP0008469_abnormal_protein_level | 0.77076296 |
| 88 | MP0000678_abnormal_parathyroid_gland | 0.76710301 |
| 89 | MP0002163_abnormal_gland_morphology | 0.75892559 |
| 90 | MP0005501_abnormal_skin_physiology | 0.75778706 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.74601612 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.74366220 |
| 93 | MP0005166_decreased_susceptibility_to | 0.73914615 |
| 94 | MP0003868_abnormal_feces_composition | 0.73396165 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.71899165 |
| 96 | MP0000609_abnormal_liver_physiology | 0.71217483 |
| 97 | MP0000604_amyloidosis | 0.71005282 |
| 98 | MP0005025_abnormal_response_to | 0.70717737 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.70092223 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.69363538 |
| 101 | MP0005671_abnormal_response_to | 0.68452581 |
| 102 | MP0003941_abnormal_skin_development | 0.68361344 |
| 103 | MP0009115_abnormal_fat_cell | 0.68030243 |
| 104 | MP0001764_abnormal_homeostasis | 0.66476819 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.66229261 |
| 106 | MP0003436_decreased_susceptibility_to | 0.62705514 |
| 107 | MP0001881_abnormal_mammary_gland | 0.62448583 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.62044893 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.61287184 |
| 110 | MP0006082_CNS_inflammation | 0.59327523 |
| 111 | MP0000249_abnormal_blood_vessel | 0.56950872 |
| 112 | MP0003787_abnormal_imprinting | 0.55983316 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.55383663 |
| 114 | MP0003123_paternal_imprinting | 0.54454401 |
| 115 | MP0000516_abnormal_urinary_system | 0.54388728 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.54388728 |
| 117 | MP0009053_abnormal_anal_canal | 0.54326004 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.53112171 |
| 119 | MP0003119_abnormal_digestive_system | 0.53104907 |
| 120 | MP0003953_abnormal_hormone_level | 0.52989661 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.52870603 |
| 122 | MP0002148_abnormal_hypersensitivity_rea | 0.51291668 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.51031128 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.50335177 |
| 125 | MP0002396_abnormal_hematopoietic_system | 0.49681118 |
| 126 | MP0002060_abnormal_skin_morphology | 0.49506635 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.49499996 |
| 128 | MP0005165_increased_susceptibility_to | 0.48962871 |
| 129 | MP0002006_tumorigenesis | 0.47305718 |
| 130 | MP0005334_abnormal_fat_pad | 0.46708281 |
| 131 | MP0004484_altered_response_of | 0.46545507 |
| 132 | MP0005266_abnormal_metabolism | 0.46125139 |
| 133 | MP0003950_abnormal_plasma_membrane | 0.46018563 |
| 134 | MP0003879_abnormal_hair_cell | 0.44518040 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.44178820 |
| 136 | MP0009780_abnormal_chondrocyte_physiolo | 0.42402113 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.41650415 |
| 138 | MP0005310_abnormal_salivary_gland | 0.41619694 |
| 139 | MP0002138_abnormal_hepatobiliary_system | 0.41165132 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.41106254 |
| 141 | MP0001188_hyperpigmentation | 0.39534460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 9.42457958 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.56240632 |
| 3 | Ventricular fibrillation (HP:0001663) | 5.53592824 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 5.20737419 |
| 5 | Malnutrition (HP:0004395) | 5.17904201 |
| 6 | Acanthocytosis (HP:0001927) | 4.87735518 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.83187186 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 4.81131848 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.61366695 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.34847483 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 4.30450302 |
| 12 | Autoimmune hemolytic anemia (HP:0001890) | 4.21581115 |
| 13 | Confusion (HP:0001289) | 4.03943628 |
| 14 | Glycosuria (HP:0003076) | 3.80779537 |
| 15 | Abnormality of urine glucose concentration (HP:0011016) | 3.80779537 |
| 16 | Rectal prolapse (HP:0002035) | 3.78052937 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.76891507 |
| 18 | Hydroxyprolinuria (HP:0003080) | 3.76891507 |
| 19 | Abdominal distention (HP:0003270) | 3.75032745 |
| 20 | Pustule (HP:0200039) | 3.61511299 |
| 21 | Decreased circulating renin level (HP:0003351) | 3.47988407 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47638749 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.47638749 |
| 24 | Cupped ribs (HP:0000887) | 3.44582875 |
| 25 | Chronic diarrhea (HP:0002028) | 3.38161733 |
| 26 | Abnormal hemoglobin (HP:0011902) | 3.37806142 |
| 27 | Fat malabsorption (HP:0002630) | 3.33743081 |
| 28 | Gastrointestinal dysmotility (HP:0002579) | 3.27716597 |
| 29 | Alkalosis (HP:0001948) | 3.22123422 |
| 30 | Abnormal biliary tract morphology (HP:0012440) | 3.14253013 |
| 31 | Cheilitis (HP:0100825) | 3.06158817 |
| 32 | Potter facies (HP:0002009) | 3.04058183 |
| 33 | Facial shape deformation (HP:0011334) | 3.04058183 |
| 34 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.00088090 |
| 35 | Villous atrophy (HP:0011473) | 3.00088090 |
| 36 | Hyperuricemia (HP:0002149) | 2.91268884 |
| 37 | Increased purine levels (HP:0004368) | 2.91268884 |
| 38 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.89484159 |
| 39 | Dehydration (HP:0001944) | 2.84269635 |
| 40 | Syncope (HP:0001279) | 2.83469661 |
| 41 | Abnormality of chloride homeostasis (HP:0011422) | 2.83440241 |
| 42 | Woolly hair (HP:0002224) | 2.83391408 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.80583336 |
| 44 | Widely patent fontanelles and sutures (HP:0004492) | 2.80550593 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.78745648 |
| 46 | B lymphocytopenia (HP:0010976) | 2.78745648 |
| 47 | Mesangial abnormality (HP:0001966) | 2.78550403 |
| 48 | Poikilocytosis (HP:0004447) | 2.76023030 |
| 49 | Xanthomatosis (HP:0000991) | 2.75432954 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.75361672 |
| 51 | Steatorrhea (HP:0002570) | 2.75285966 |
| 52 | Hyperphosphaturia (HP:0003109) | 2.73199137 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.72976300 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.70185386 |
| 55 | Abnormality of vitamin B metabolism (HP:0004340) | 2.68603501 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.68521895 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.68414835 |
| 58 | Hypophosphatemia (HP:0002148) | 2.57579916 |
| 59 | Pili torti (HP:0003777) | 2.53142486 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.52834025 |
| 61 | Hyperactive renin-angiotensin system (HP:0000841) | 2.52644250 |
| 62 | Palpitations (HP:0001962) | 2.51942639 |
| 63 | Abnormality of the gastric mucosa (HP:0004295) | 2.50134444 |
| 64 | Cerebral palsy (HP:0100021) | 2.48434498 |
| 65 | Hyperglycinuria (HP:0003108) | 2.46239553 |
| 66 | Biliary tract neoplasm (HP:0100574) | 2.44267308 |
| 67 | Thin bony cortex (HP:0002753) | 2.43611590 |
| 68 | Megaloblastic anemia (HP:0001889) | 2.41849206 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.41324196 |
| 70 | Focal segmental glomerulosclerosis (HP:0000097) | 2.40446134 |
| 71 | Ventricular arrhythmia (HP:0004308) | 2.39113439 |
| 72 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36465400 |
| 73 | Fragile skin (HP:0001030) | 2.35503633 |
| 74 | Abnormal albumin level (HP:0012116) | 2.35174628 |
| 75 | Hypoalbuminemia (HP:0003073) | 2.35174628 |
| 76 | Micronodular cirrhosis (HP:0001413) | 2.34714926 |
| 77 | Pancreatitis (HP:0001733) | 2.34482791 |
| 78 | Male infertility (HP:0003251) | 2.34125355 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.32256107 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.31386829 |
| 81 | Glomerulonephritis (HP:0000099) | 2.31190274 |
| 82 | Ankyloglossia (HP:0010296) | 2.30219518 |
| 83 | Enlarged epiphyses (HP:0010580) | 2.28663483 |
| 84 | Abnormal urine phosphate concentration (HP:0012599) | 2.27683855 |
| 85 | Combined immunodeficiency (HP:0005387) | 2.27391962 |
| 86 | Abnormality of magnesium homeostasis (HP:0004921) | 2.26958560 |
| 87 | Symptomatic seizures (HP:0011145) | 2.25471017 |
| 88 | Flat acetabular roof (HP:0003180) | 2.25441810 |
| 89 | Nephritis (HP:0000123) | 2.25051538 |
| 90 | Increased IgE level (HP:0003212) | 2.24725354 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.24182218 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 2.23973534 |
| 93 | Hepatic necrosis (HP:0002605) | 2.23179394 |
| 94 | Hypotension (HP:0002615) | 2.21389455 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20077857 |
| 96 | Premature loss of primary teeth (HP:0006323) | 2.18233878 |
| 97 | Increased mean platelet volume (HP:0011877) | 2.18196880 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16848487 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 2.16848487 |
| 100 | Increased hepatocellular lipid droplets (HP:0006565) | 2.14978462 |
| 101 | Hyperammonemia (HP:0001987) | 2.14821948 |
| 102 | Epidermoid cyst (HP:0200040) | 2.13448862 |
| 103 | Milia (HP:0001056) | 2.12873057 |
| 104 | Nausea (HP:0002018) | 2.11016170 |
| 105 | Hyperphosphatemia (HP:0002905) | 2.09083561 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.06108151 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 2.05631964 |
| 108 | Goiter (HP:0000853) | 2.04449416 |
| 109 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04011591 |
| 110 | Wide cranial sutures (HP:0010537) | 2.03117271 |
| 111 | Macrocytic anemia (HP:0001972) | 2.03071962 |
| 112 | Gingivitis (HP:0000230) | 2.02717247 |
| 113 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02709068 |
| 114 | Abnormal glucose tolerance (HP:0001952) | 2.02641422 |
| 115 | Abnormality of complement system (HP:0005339) | 2.02158201 |
| 116 | Prolonged QT interval (HP:0001657) | 2.01639864 |
| 117 | Metabolic alkalosis (HP:0200114) | 2.00921104 |
| 118 | Abnormality of placental membranes (HP:0011409) | 2.00880407 |
| 119 | Amniotic constriction ring (HP:0009775) | 2.00880407 |
| 120 | Abnormal EKG (HP:0003115) | 2.00604183 |
| 121 | Subcapsular cataract (HP:0000523) | 1.99802944 |
| 122 | Complement deficiency (HP:0004431) | 1.99676723 |
| 123 | Reticulocytopenia (HP:0001896) | 1.98944894 |
| 124 | Plantar hyperkeratosis (HP:0007556) | 1.98485297 |
| 125 | Metabolic acidosis (HP:0001942) | 1.98351344 |
| 126 | Hyperparathyroidism (HP:0000843) | 1.96636241 |
| 127 | Fragile nails (HP:0001808) | 1.95692596 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.95398252 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94633823 |
| 130 | Protuberant abdomen (HP:0001538) | 1.93855503 |
| 131 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93115101 |
| 132 | Chorioretinal atrophy (HP:0000533) | 1.93089232 |
| 133 | Gout (HP:0001997) | 1.93025960 |
| 134 | Nephrolithiasis (HP:0000787) | 1.92053008 |
| 135 | Abnormality of the costochondral junction (HP:0000919) | 1.89022729 |
| 136 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88804921 |
| 137 | Lethargy (HP:0001254) | 1.88201858 |
| 138 | Mitochondrial inheritance (HP:0001427) | 1.87749358 |
| 139 | Irritability (HP:0000737) | 1.87190909 |
| 140 | Trismus (HP:0000211) | 1.87165940 |
| 141 | Abnormality of the 1st metacarpal (HP:0010009) | 1.87076147 |
| 142 | Posterior subcapsular cataract (HP:0007787) | 1.86702582 |
| 143 | Delayed epiphyseal ossification (HP:0002663) | 1.86155732 |
| 144 | Glomerulosclerosis (HP:0000096) | 1.84357300 |
| 145 | Colon cancer (HP:0003003) | 1.83845461 |
| 146 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83722551 |
| 147 | Abnormal platelet volume (HP:0011876) | 1.83669229 |
| 148 | Renal tubular acidosis (HP:0001947) | 1.81870452 |
| 149 | Growth hormone excess (HP:0000845) | 1.78267543 |
| 150 | Vomiting (HP:0002013) | 1.69362322 |
| 151 | Hypocalcemia (HP:0002901) | 1.68843968 |
| 152 | Skin rash (HP:0000988) | 1.65839004 |
| 153 | Hypokalemia (HP:0002900) | 1.65549090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 7.53363220 |
| 2 | FRK | 5.58193167 |
| 3 | MST1R | 5.46654438 |
| 4 | NME1 | 4.27457233 |
| 5 | MST4 | 4.00259137 |
| 6 | PRKG2 | 3.46248149 |
| 7 | NUAK1 | 2.80258592 |
| 8 | MAP2K2 | 2.74603634 |
| 9 | EPHA3 | 2.20700422 |
| 10 | TNIK | 2.08512696 |
| 11 | EPHA2 | 2.03827722 |
| 12 | PBK | 2.02237994 |
| 13 | MAP3K2 | 1.97314861 |
| 14 | MAP2K6 | 1.96044528 |
| 15 | PIK3CA | 1.93901804 |
| 16 | EPHB2 | 1.88620687 |
| 17 | FGFR4 | 1.79179938 |
| 18 | GRK6 | 1.76990838 |
| 19 | RIPK1 | 1.74637930 |
| 20 | MET | 1.68195525 |
| 21 | NLK | 1.63832794 |
| 22 | PTK6 | 1.62546105 |
| 23 | TYK2 | 1.54401554 |
| 24 | STK39 | 1.53424699 |
| 25 | TTK | 1.41353910 |
| 26 | ADRBK2 | 1.39916869 |
| 27 | TESK1 | 1.39176962 |
| 28 | MAP3K10 | 1.30498670 |
| 29 | MAP3K11 | 1.30481222 |
| 30 | TAOK3 | 1.25670354 |
| 31 | CASK | 1.23794634 |
| 32 | EPHA4 | 1.19651608 |
| 33 | STK24 | 1.18666832 |
| 34 | KSR2 | 1.10268544 |
| 35 | ERBB2 | 1.09027392 |
| 36 | FGFR3 | 1.08732649 |
| 37 | MYLK | 1.06946619 |
| 38 | IRAK1 | 1.06325707 |
| 39 | MAP3K8 | 0.92722693 |
| 40 | IRAK3 | 0.89514820 |
| 41 | MAP2K1 | 0.87816376 |
| 42 | DDR2 | 0.87246450 |
| 43 | BMPR2 | 0.82885501 |
| 44 | AKT3 | 0.80235731 |
| 45 | AURKB | 0.80007377 |
| 46 | TLK1 | 0.79111285 |
| 47 | MATK | 0.78421910 |
| 48 | ERN1 | 0.77893843 |
| 49 | PRKCI | 0.76826191 |
| 50 | OXSR1 | 0.71821028 |
| 51 | PTK2 | 0.70180191 |
| 52 | MAP3K1 | 0.69173700 |
| 53 | PRKAA2 | 0.66471547 |
| 54 | PKN2 | 0.64858162 |
| 55 | DAPK2 | 0.64221795 |
| 56 | TAOK1 | 0.60817392 |
| 57 | SCYL2 | 0.60339704 |
| 58 | MAPK11 | 0.60338558 |
| 59 | STK10 | 0.60259249 |
| 60 | PAK4 | 0.58074228 |
| 61 | GRK1 | 0.57879093 |
| 62 | KIT | 0.54941310 |
| 63 | PRKCZ | 0.54692172 |
| 64 | FER | 0.51714328 |
| 65 | WNK4 | 0.51636299 |
| 66 | BMX | 0.51524550 |
| 67 | PDK1 | 0.51322131 |
| 68 | PASK | 0.50505384 |
| 69 | JAK1 | 0.50256186 |
| 70 | TESK2 | 0.48724961 |
| 71 | MAP3K7 | 0.47442163 |
| 72 | CAMK2D | 0.47086000 |
| 73 | IKBKE | 0.46690637 |
| 74 | PIM1 | 0.45969813 |
| 75 | STK38L | 0.43471231 |
| 76 | CSF1R | 0.39867467 |
| 77 | SYK | 0.39022781 |
| 78 | PRKCD | 0.38621291 |
| 79 | TEC | 0.38611696 |
| 80 | CDK9 | 0.38393815 |
| 81 | JAK2 | 0.38321837 |
| 82 | ERBB4 | 0.37646721 |
| 83 | LATS1 | 0.36925785 |
| 84 | MAP3K12 | 0.36823722 |
| 85 | PRKAA1 | 0.35858572 |
| 86 | ITK | 0.34996481 |
| 87 | NME2 | 0.34599187 |
| 88 | TBK1 | 0.33901896 |
| 89 | PAK1 | 0.33666716 |
| 90 | PRKCA | 0.33495379 |
| 91 | ABL2 | 0.32843857 |
| 92 | PIM2 | 0.32763637 |
| 93 | CAMK2G | 0.30657254 |
| 94 | BCR | 0.30272635 |
| 95 | FYN | 0.29636547 |
| 96 | PAK3 | 0.29466531 |
| 97 | MUSK | 0.29263412 |
| 98 | LIMK1 | 0.29239943 |
| 99 | DMPK | 0.28690003 |
| 100 | CSNK1A1 | 0.28096227 |
| 101 | YES1 | 0.27673873 |
| 102 | PRKCE | 0.27491384 |
| 103 | MAP3K3 | 0.27286089 |
| 104 | MELK | 0.27137799 |
| 105 | TXK | 0.27039000 |
| 106 | BMPR1B | 0.25995781 |
| 107 | CAMK2A | 0.25695666 |
| 108 | LYN | 0.25533129 |
| 109 | DAPK1 | 0.25505774 |
| 110 | IGF1R | 0.25346076 |
| 111 | MAPKAPK2 | 0.24582898 |
| 112 | PRKACA | 0.23446722 |
| 113 | RET | 0.23343833 |
| 114 | ROCK1 | 0.23096589 |
| 115 | JAK3 | 0.23040998 |
| 116 | MAP4K1 | 0.22887713 |
| 117 | CAMK2B | 0.21792480 |
| 118 | RIPK4 | 0.21166816 |
| 119 | ZAP70 | 0.20784732 |
| 120 | PDPK1 | 0.19926648 |
| 121 | RPS6KB2 | 0.19918775 |
| 122 | PRKACG | 0.19821949 |
| 123 | LRRK2 | 0.19806782 |
| 124 | CSK | 0.18547611 |
| 125 | ACVR1B | 0.18326536 |
| 126 | CDK19 | 0.18124018 |
| 127 | NEK9 | 0.17332558 |
| 128 | SRC | 0.17130214 |
| 129 | CDK6 | 0.16830146 |
| 130 | EPHB1 | 0.15551574 |
| 131 | DYRK1B | 0.15359726 |
| 132 | CAMKK1 | 0.14451938 |
| 133 | FGR | 0.14306520 |
| 134 | CDC42BPA | 0.14248379 |
| 135 | PRKCQ | 0.13749055 |
| 136 | PDGFRA | 0.12874234 |
| 137 | EIF2AK1 | 0.12872918 |
| 138 | PDK2 | 0.12392393 |
| 139 | MAP3K9 | 0.12318699 |
| 140 | BLK | 0.11095041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.32564834 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.45063995 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.23755333 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.22177391 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.14153038 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.07510099 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.68545978 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.52841274 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49200239 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.34395923 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.21343883 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.19951576 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.18648711 |
| 14 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.17642013 |
| 15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.10968265 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98308943 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.82125359 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.79501042 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78983279 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74933986 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74685107 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71074739 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.70311656 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57445805 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.56376500 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.55686250 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36124457 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33126160 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32658608 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.30393804 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28810469 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25316551 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20362734 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.13084445 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10417061 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09770934 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07151451 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05467418 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05432000 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04336265 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01873880 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01206516 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97074618 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96578070 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96320393 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96316395 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95227255 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93738062 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91674556 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90302613 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90089210 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88902796 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86255873 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85504516 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83846467 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.83500030 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82513354 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.81574471 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79582087 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79215268 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78630666 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78599623 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77877846 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77254235 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71585472 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60821005 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60440022 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60127494 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59355103 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58928205 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58903623 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57832138 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.52990189 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52549253 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52106686 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51832316 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50444980 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.49190187 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48578480 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46833958 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46440399 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46223347 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46078089 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44362547 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42369992 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40843680 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38179976 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.37930200 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32525024 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31795066 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.31199749 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31188087 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29832088 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.29055296 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.27726607 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25831255 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25574630 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24333159 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23561985 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23356412 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.23190190 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.21671861 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20357116 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20192954 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20161864 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20152809 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.19908707 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.19728189 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19049702 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.17967799 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.16260012 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16038743 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15878852 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14103687 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13193964 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12634636 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.12267323 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.11568006 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11523202 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11340509 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11018199 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | 0.10874763 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.10360977 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.10029105 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.07186400 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05997494 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.04235969 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03785158 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.03218416 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02395986 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00603434 |

